poisar

Stocks · News reference

Citigroup Upgrades Agilon Health to Neutral, Raises Price Target to $115

BenzingaAug 11, 2026, 12:22 PMBenzinga Newsdesk

Citigroup analyst Daniel Grosslight upgrades Agilon Health (NYSE:AGL) from Sell to Neutral and raises the price target from $105 to $115.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Aug 11, 2026, 12:22 PM
Checked
Aug 11, 2026, 12:22 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading